Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5445907 | 0.82 | MAPT (0.75) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL8956455 | 0.82 | MAPT (0.75) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL5081276 | 0.79 | NOX1 (0.85) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL8956349 | 0.79 | NOX1 (0.85) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL10189868 | 0.78 | EPHX1 (0.60) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL11018889 | 0.78 | MAPT (0.57) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL27885438 | 0.78 | MAPT (0.57) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL526059 | 0.78 | MAPT (0.63) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| SCHEMBL10977035 | 0.76 | MAPT (0.55) | NOX1MAPTKDM4ENPC1ALDH1A1 | |
| Thiourea SCHEMBL1991944 | 0.76 | MAPT (0.73) | NOX1MAPTKDM4ENPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| CN-1254281-A | HIV and cancer treatment | PROCTER & GAMBLE (US) | 2000-05-24 | — | — | CN | disclosed |